Joseph P. Lucia & Associates, LLC Amgen Inc Transaction History

Joseph P. Lucia & Associates, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$230.71 - $256.74 $17,303 - $19,255	-75 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$219.27 - $242.57 $16,445 - $18,192	75 New	75 $18,000
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $14,916 - $17,070	-75 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$216.38 - $257.67 $16,228 - $19,325	75 New	75 $17,000
Q3 2020 Oct 20, 2020	SELL	$234.65 - $260.95 $17,598 - $19,571	-75 Closed	0 $0
Q2 2019 Jul 23, 2019	SELL	$166.7 - $195.41 $2.42 Million - $2.84 Million	-14,541 Reduced 99.49%	75 $14,000
Q1 2019 May 02, 2019	BUY	$180.87 - $203.88 $2.64 Million - $2.98 Million	14,616 New	14,616 $75,000

3,055

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.